“Clot-busting drugs first, devices second” has been repeated for years. That playbook now misses critical nuance. In modern acute ischaemic stroke services, mechanical thrombectomy is central for large vessel occlusions, and intravenous thrombolysis is a partner, not a master. I will set out how the approaches differ, where they complement each other, and how to decide quickly and safely under pressure.

Top Treatment Options: Mechanical Thrombectomy vs Thrombolysis for Acute Ischaemic Stroke

1. Mechanical Thrombectomy: Gold Standard for Large Vessel Occlusion

For large vessel occlusion, mechanical thrombectomy is the procedural workhorse. I use it to physically extract thrombus from proximal cerebral arteries. The goal is simple. Restore perfusion fast and preserve viable brain tissue.

In practice, the technique offers several advantages over drugs alone:

• High recanalisation rates in proximal occlusions where clot burden is substantial.

• Rapid reperfusion when the device captures or aspirates the clot on the first pass.

• Flexibility to treat patients who are ineligible for intravenous thrombolysis.

• Targeted action with less systemic exposure to lytic agents.

The key is disciplined workflow. Pre-notification, parallel processing in the emergency department, and a ready catheter lab. I prioritise imaging triage, vascular access, and immediate device deployment. Speed matters. Outcomes hinge on minutes.

Critics sometimes argue that distal emboli and reperfusion injury blunt benefit. They are right to an extent. But with careful technique, selective device choice, and gentle reperfusion, risks stay low while benefit stays high.

2. Intravenous Thrombolysis: Time-Sensitive Medical Management

Intravenous thrombolysis remains a vital part of acute ischemic stroke management when given early. It can lyse small or distal clots that are less accessible to catheters. It also buys time while a thrombectomy team prepares.

Evidence-based timing is specific. As ESO Guidelines indicate, alteplase within 4.5 hours improves outcomes, and selection by imaging can extend benefit in defined scenarios. The protocol is well drilled: confirm diagnosis, exclude haemorrhage, assess contraindications, administer weight-based dosing, and monitor closely.

Practical caveats apply. Anticoagulation status complicates decisions, renal function can shape risk, and blood pressure control is not optional. I also consider pre-stroke disability, frailty, and the real-world bleed risk profile.

Used judiciously, lysis remains a powerful tool. It is not redundant. It is part of an integrated pathway with mechanical thrombectomy.

3. Bridging Therapy: Combined Thrombolysis and Thrombectomy Approach

Bridging therapy layers intravenous thrombolysis before mechanical thrombectomy. The logic is clear. Prime the clot chemically, then remove it mechanically. Some centres prefer direct thrombectomy to avoid bleeding risk and delay.

Current comparative data are mixed, which is unsurprising given patient heterogeneity. In one synthesis, patients receiving combination therapy showed improved functional independence in selected profiles, while direct thrombectomy yielded similar outcomes in others with fewer haemorrhages. As Bridging Thrombolysis versus Direct Mechanical Thrombectomy outlines, centre logistics, drug choice, and workflow timing influence both efficacy and safety.

My approach is pragmatic. If intravenous thrombolysis can start without delaying groin puncture, I consider it. If transfer delays are likely or bleeding risk is high, I move straight to mechanical thrombectomy.

Success Rates and Functional Outcomes Comparison

Outcomes depend on occlusion site, collateral status, onset-to-reperfusion time, and first-pass success. Mechanical thrombectomy tends to yield higher successful reperfusion rates for proximal occlusions. Combined therapy can increase early recanalisation before the patient reaches the lab. Direct thrombectomy simplifies the pathway and can reduce haemorrhage risk in some cohorts.

Functional outcomes follow the physics. Faster and fuller reperfusion predicts independence at 90 days. That is the signal. Technique and timing amplify or blunt it.

• Mechanical thrombectomy: strongest effect in internal carotid and M1 occlusions.

• Thrombolysis: useful for distal clots and early microreperfusion.

• Bridging therapy: beneficial where door-to-puncture is short and bleeding risk is contained.

Key Selection Criteria for Each Treatment Approach

Selection is the real art. I weigh vessel status, imaging, time, and bleeding risk. Updated recommendations standardise much of this thinking. As Guidelines for the Early Management of Patients With detail, protocols map candidates to intravenous thrombolysis, mechanical thrombectomy, or both, depending on window and imaging.

In practice, I consider the following:

• Occlusion site and clot burden suggest procedural feasibility.

• Core-infarct size and perfusion mismatch predict salvageable tissue.

• Comorbidity and bleeding risk shape drug decisions.

• Transfer time and team readiness influence pathway choice.

I also adapt to hospital context. Direct-to-angio protocols reduce delay. Rural transfers need different thresholds. One size does not fit all.

Clinical factor	Primary option
Proximal LVO with good collaterals	Mechanical thrombectomy, consider bridging if no delay
Distal occlusion without access route	Intravenous thrombolysis if eligible
High bleed risk or recent major surgery	Direct thrombectomy where anatomy allows
Extended window with small core and mismatch	Mechanical thrombectomy pathway

Technical Approaches and Devices in Mechanical Thrombectomy

Stent Retriever Devices: Mechanism and Clinical Performance

Stent retrievers deploy across the thrombus, integrate with clot, then retrieve under aspiration. I aim for a firm device-clot interface and gentle traction. The tactic reduces distal emboli and supports en bloc removal.

Clinical performance is strong in tough, fibrin-rich clots. The device scaffolds the artery, restores some flow, and helps stabilise the first pass. It also allows controlled re-sheathing when resistance feels unsafe.

• Strengths: control, versatility, and predictable performance in proximal M1 and ICA occlusions.

• Limitations: tortuosity, calcified plaque, and friable distal clot fragments.

Direct Aspiration Technology: Vacuum-Based Clot Removal

Aspiration systems apply negative pressure through large-bore catheters. I seat the catheter at the face of the thrombus, confirm purchase, then maintain steady suction. When successful, the clot yields as a single column.

This approach can be faster with suitable anatomy. It reduces device exchanges and may shorten procedure time. It is particularly effective for softer, erythrocyte-rich thrombi and straight arterial segments.

Yet anatomy rules. Pronounced tortuosity or atherosclerotic ledges can limit catheter advancement. In those cases, I switch or combine techniques.

Combined Techniques: Maximising First-Pass Success

Many teams now combine a stent retriever with aspiration. The strategy increases first-pass effect and reduces distal embolisation. I often anchor the stent, maintain suction, and withdraw as one unit under proximal flow control.

This hybrid method balances control with speed. It also offers a safety net. If one technique stalls, the other maintains momentum without delay.

Device Selection Based on Clot Location and Characteristics

Device choice is not arbitrary. I match the tool to the clot and the artery:

• Fibrin-heavy, organised clot: stent retriever first, assisted by aspiration.

• Softer red clot in a straight segment: primary aspiration with large-bore catheter.

• Tandem lesions with cervical stenosis: staged angioplasty, then mechanical thrombectomy.

• Distal M2 or beyond with fragile branches: smaller profile devices or medical strategy.

I also factor in operator familiarity. Fluency matters when seconds matter.

Eligibility and Time Windows for Mechanical Thrombectomy

Standard Time Window (0-6 Hours): Immediate Intervention Criteria

Within the standard window, selection is straightforward. Clear onset, disabling deficit, and proximal occlusion guide the decision. I confirm a small core on non-contrast CT with an acceptable ASPECTS, then proceed.

The operational rule is simple. No delay for marginal tests. Once eligibility is clear, I activate the pathway and move to the lab.

Extended Time Window (6-24 Hours): Advanced Imaging Selection

In the extended window, imaging drives judgement. I look for perfusion mismatch that signals salvageable tissue. Collateral status and clinical-CT mismatch add confidence.

If the core is small and the penumbra is sizeable, mechanical thrombectomy remains reasonable. If the core is large with minimal mismatch, the balance shifts away from intervention.

Imaging Protocols: ASPECTS Score and Perfusion Mismatch

Imaging protocol adherence avoids errors. Non-contrast CT excludes haemorrhage and estimates core via ASPECTS. CT angiography maps occlusion. Perfusion studies define mismatch in extended cases.

I also check cervical vessels for tandem lesions. Aortic arch anatomy can influence access planning. Preparation in the scanner saves time in the lab.

Special Populations: Mild Strokes and Large Core Infarcts

Minor deficits with proximal occlusion present a dilemma. Some of these patients deteriorate. I discuss risks and consider imaging predictors of progression.

Large core infarcts demand restraint. Where oedema risk is high and mismatch minimal, the chance of harm rises. I consider age, comorbidity, and care goals before committing to mechanical thrombectomy.

Complications and Safety Profile

Common Complications of Mechanical Thrombectomy Procedures

Complications are uncommon with disciplined technique, but they occur. The typical list includes access site haematoma, contrast nephropathy, distal embolisation, and vessel dissection. Careful wire handling and flow control reduce risk.

I also monitor for reperfusion injury. Blood pressure targets and gradual reperfusion help limit haemorrhagic conversion.

Symptomatic Intracerebral Haemorrhage Risk Factors

Bleeding risk increases with large cores, uncontrolled hypertension, and aggressive blood pressure swings post-procedure. Concomitant thrombolysis adds a modest increment in some patients.

Mitigation is procedural and medical. Gentle device manipulation, conservative passes, and strict post-anaesthesia care lower the odds. Risk never falls to zero. It should fall to acceptable.

Procedural Complications: Vessel Perforation and Embolisation

Perforation is rare but serious. Warning signs include resistance, wire prolapse, and contrast extravasation. My response is immediate. Stop, reverse anticoagulation if appropriate, and call neurosurgery if needed.

Embolisation to a new territory is another hazard. Proximal flow arrest and continuous aspiration lessen that risk. So does patience. Forcing a pass is not a strategy.

Management Strategies for Post-Procedure Complications

After mechanical thrombectomy, I follow a standard bundle:

• Neurological checks at defined intervals to catch early decline.

• Blood pressure control with narrow targets for the first 24 hours.

• Repeat imaging if neurological status shifts or headache escalates.

• Antithrombotic planning based on stroke mechanism and imaging findings.

Escalation pathways must be pre-agreed. If haemorrhage occurs, I reverse agents and manage intracranial pressure. If re-occlusion is suspected, I reassess urgently.

Future Directions in Acute Stroke Management

The field is moving quickly. Several developments are reshaping practice:

• Smaller profile aspiration systems that reach further without tortuous harm.

• Next-generation stent retrievers with improved clot integration.

• Angio-suite CT that compresses imaging and puncture into one room.

• AI triage for pre-hospital imaging to speed mechanical thrombectomy activation.

Two shifts deserve emphasis. First, better selection for large cores using refined thresholds and physiology, not size alone. Second, rapid inter-hospital transfer models that treat time like a drug dose.

The goal is consistent. Faster decisions, fewer delays, and safer reperfusion. That is how outcomes improve across systems.

Frequently Asked Questions

What is the difference between mechanical thrombectomy and thrombolysis in stroke treatment?

Mechanical thrombectomy physically removes clot using catheters and devices. Intravenous thrombolysis uses medication to dissolve clot. For large vessel occlusion, mechanical thrombectomy achieves higher reliable reperfusion. Thrombolysis helps in smaller or distal clots and as a bridge. The practical choice is not binary. It is thrombectomy vs thrombolysis in theory, but in practice they can complement each other.

How long after stroke symptoms can mechanical thrombectomy be performed?

Standard treatment is prompt once eligibility is clear. Selection outside the earliest window relies on imaging to identify salvageable brain. I proceed when the core is limited and mismatch is present. Time is critical, but physiology guides the late decisions.

What are the success rates of mechanical thrombectomy for acute ischaemic stroke?

Success depends on occlusion site, clot composition, and first-pass performance. Proximal occlusions respond well, especially with combined aspiration and stent retrieval. Good technique and tight workflow improve the odds of independence at 90 days.

Which patients benefit most from bridging therapy versus direct thrombectomy?

Bridging therapy suits patients who can receive lysis without delaying puncture and without undue bleed risk. Direct mechanical thrombectomy is attractive when transfer delays exist or bleeding risk is notable. Local logistics and patient profile shape the better option.

What are the major risks associated with mechanical thrombectomy procedures?

Main risks include intracranial haemorrhage, distal embolisation, vessel dissection or perforation, contrast injury, and access site complications. With careful technique and post-procedure management, overall safety is favourable.

How is the choice between stent retrievers and aspiration devices made during thrombectomy?

I match device to anatomy and clot. Fibrin-heavy, proximal thrombi favour a stent retriever with aspiration support. Softer clots in straight vessels favour primary aspiration. I switch or combine to maximise first-pass success.